Search

everythinglearnresearchcommunity

for

Search:↓

A boy with severe Vitamin D-resistant rickets did not respond to treatment and lacked a common symptom, suggesting a need for alternative treatments.

Non-invasive imaging helped diagnose a woman's severe hormone imbalance and diabetes, and medication successfully treated her condition.

OR-101 shows promise for treating alopecia areata by improving hair growth.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Thallium poisoning can cause serious eye problems and other severe health issues.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

Gefitinib can cause hair and eyebrow darkening.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

Melatonin can help prevent and treat skin damage caused by gamma rays.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Ritlecitinib helps hair regrowth and reduces emotional and functional burdens in alopecia areata.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

Ayurvedic treatment improved hypothyroidism in a 30-year-old man.

A child with a rare type of rickets showed some improvement with high doses of vitamin D, but such conditions often respond poorly to treatment.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

The new test can measure very small amounts of testosterone in hair, and grinding the hair up first gives more accurate results.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

The IBHRS is now operational.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

Older patients with new retinal lesions may have cancer, and local radiation might not stop it from spreading.

Medical treatments like chemotherapy and radiotherapy can harm sperm production, so freezing sperm before treatment is important for men who want children later.

Gamma-ray exposure improves genome editing efficiency in mice using the i-GONAD method.

Sacituzumab govitecan is effective but has side effects like hair loss and diarrhea in treating metastatic triple-negative breast cancer.